Fiche du document
15 janvier 2020
- doi: 10.53738/REVMED.2020.16.676-77.0008
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.676-77.0008
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/31961074
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_CA182C5C86403
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Mots-clés
Analgesics, Opioid; Behavior, Addictive; Humans; Opioid-Related Disorders; Pain ManagementSujets proches
Therapy Pain management OpiatesCiter ce document
M. Vogel et al., « Addictions [Addictions] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.676-77.0008
Métriques
Partage / Export
Résumé
This article describes a new form of administration of inhaled prescribed heroin currently under investigation. It underlines the particularity of opioid agonist prescription in jail and presents new perspectives in using psilocybin in addiction medicine treatment. A brief literature review about vaping confirms its interest in quitting cigarette, with a cost of addiction to vaping and recent worrisome reports of chemical pneumonia. Finally, the withdrawal of WHO guidelines on opiates use in pain management, in the context of a suspicion of conflict of interest, underlines the sensible balance between over- and under- prescription of opiates in analgesic treatment.